Testicular cancer in Iceland 2000-2009: Incidence and survival;Krabbamein í eistum á íslandi 2000-2009: Nýgengi og lífshorfur

Laeknabladid

Volumn 97, Issue 3, 2011, Pages 143-148

  Orrason, A W ^a   Agnarsson, B A ^a   Geirsson, G ^a   Helgason, H H ^b   Gudbjartsson, T ^b  

^a UNIVERSITY OF ICELAND   (Iceland)

^b Rannsóknarstofu Ímeinafræoi ^*  (Iceland)

Author keywords

Incidence; Non seminoma; Seminoma; Survival; Testicular germ cell tumours; Treatment

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; COMPARATIVE STUDY; HUMAN; ICELAND; INCIDENCE; MALE; MIDDLE AGED; MORTALITY; NEOPLASM; NONSEMINOMATOUS GERM CELL TUMOR; PATHOLOGY; RETROSPECTIVE STUDY; SEMINOMA; SURVIVAL; SURVIVAL RATE; TESTIS TUMOR; TIME; TREATMENT OUTCOME;

ADULT; AGED; HUMANS; ICELAND; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; RETROSPECTIVE STUDIES; SEMINOMA; SURVIVAL ANALYSIS; SURVIVAL RATE; TESTICULAR NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79952651282     PISSN: 00237213     EISSN: 16704959     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Huyghe E, Matsuda T, Thonneau P. Increasing incidence of testicular cancer worldwide: a review. J Urol 2003; 170: 5-11. (Pubitemid 36734401)
2. www.krabbameinsskra.is
3. www-dep.iarc.fr
4. Dieckmann KP, Pichlmeier U. Clinical epidemiology of testicular germ cell tumors. World J Urol 2004; 22: 2-14. (Pubitemid 41406567)
5. McGlynn KA, Devesa SS, Graubard BI, Castle PE. Increasing incidence of testicular germ cell tumors among black men in the United States. J Clin Oncol 2005; 23: 5757-61.
6. Schmiedel S, Schuz J, Skakkebaek NE, Johansen C. Testicular Germ Cell Cancer Incidence in an Immigration Perspective, Denmark, 1978 to 2003. J Urol 2010; 183: 1378-82.
7. Tseng A Jr, Horning SJ, Freiha FS, Resser KJ, Hannigan JF Jr, Torti FM. Gynecomastia in testicular cancer patients. Prognostic and therapeutic implications. Cancer 1985; 56: 2534-8.
8. Shaw J. Diagnosis and treatment of testicular cancer. Am Fam Physician 2008; 77: 469-74.
9. Gudbjartsson T, Magnusson K, Bergthorsson J, et al. A population-based analysis of increased incidence and improved survival of testicular cancer patients in Iceland. Scand J Urol Nephrol 2003; 37: 292-8. (Pubitemid 37188193)
10. Agnarsson BA, Gudbjartsson T, Einarsson GV, et al. Testicular germ cell tumours in Iceland: a nationwide clinicopathological study. APMIS 2006; 114: 779-83. (Pubitemid 44673230)
11. Shintaku I, Satoh M, Okajima E, et al. Survival of metastatic germ cell cancer patients assessed by international germ cell consensus classification in Japan. Jpn J Clin Oncol 2008; 38: 281-7. (Pubitemid 351583992)
12. Guobjartsson T, Björnsson R, Magnússon K, Björnsson S, Einarsson GV. Góoar lífshorfur karla meo sáokrabbamein: afturskyggn rannsókn á íslenskum körlum greindum 1971-1990. Læknablaoio 1996; 82: 202-8.
13. Björnsson R, Guobjartsson T, Magnússon K, Guolaugsson EG, Björnsson S, Einarsson GV. Frjófrumuæxli í eistum önnur en sáokrabbamein: gerbreyttar horfur: afturskyggn rannsókn á íslandi 1971-1995. Læknablaoio 1997; 7: 477-85.
14. Boden G, Gibb R. Radiotherapy and testicular neoplasms. Lancet 1951; 2: 1195-7.
15. Richiardi L, Bellocco R, Adami HO, et al. Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiol Biomarkers Prev 2004; 13: 2157-66. (Pubitemid 40054312)
16. Bergthorsson JT, Agnarsson BA, Gudbjartsson T, et al. A genome-wide study of allelic imbalance in human testicular germ cell tumors using microsatellite markers. Cancer Genet Cytogenet 2006; 164: 1-9. (Pubitemid 41823908)
17. Dong C, Hemminki K. Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families. Int J Cancer 2001; 92: 144-50. (Pubitemid 32187044)
18. Starr JR, Chen C, Doody DR, et al. Risk of testicular germ cell cancer in relation to variation in maternal and offspring cytochrome p450 genes involved in catechol estrogen metabolism. Cancer Epidemiol Biomarkers Prev 2005; 14: 2183-90. (Pubitemid 41603266)
19. Chia VM, Quraishi SM, Devesa SS, Purdue MP, Cook MB, McGlynn KA. International trends in the incidence of testicular cancer, 1973-2002. Cancer Epidemiol Biomarkers Prev; 19: 1151-9.
20. Osswald M, Harlan LC, Penson D, Stevens JL, Clegg LX. Treatment of a population based sample of men diagnosed with testicular cancer in the United States. Urol Oncol 2009; 27: 604-10.
21. Oldenburg J, Lehne G, Fossa SD. Testikkelkreft. Tidsskr Nor Laegeforen 2008; 128: 457-60.
22. Sundstrom J, Salminen E, Nurmi M, et al. Management of testicular cancer - 16 years' experience from southwest Finland. Scand J Urol Nephrol 2001; 35: 21-5. (Pubitemid 32210069)
23. Oshima A, Kitagawa T, Ajiki W, Tsukuma H, Takenaka S, Iura A. Survival of testicular cancer patients in Osaka, Japan. Jpn J Clin Oncol 2001; 31: 438-43. (Pubitemid 33039752)
24. Aareleid T, Sant M, Hedelin G. Improved survival for patients with testicular cancer in Europe since 1978. Eur J Cancer 1998; 34: 2236-40. (Pubitemid 29036892)
25. Bokemeyer C, Nowak P, Haupt A, et al. Treatment of brain metastases in patients with testicular cancer. J Clin Oncol 1997; 15: 1449-54. (Pubitemid 27167379)
26. Stenman UH. Testicular cancer: the perfect paradigm for marker combinations. Scand J Clin Lab Invest 2005; 65: 181-8.
27. Union for International Cancer Control. 6th ed. Wiley-Liss, New York 2002.